Inactive Instrument

ZINZINO Share Price Swiss Exchange

Equities

SE0002480442

Other Specialty Retailers

End-of-day quote Swiss Exchange
- SEK - Intraday chart for ZINZINO

Financials

Sales 2024 * 2.06B 195M 16.31B Sales 2025 * 2.25B 213M 17.8B Capitalization 2.51B 238M 19.88B
Net income 2024 * 186M 17.66M 1.47B Net income 2025 * 212M 20.13M 1.68B EV / Sales 2024 * 1.39 x
Net Debt 2024 * 355M 33.7M 2.81B Net Debt 2025 * 459M 43.57M 3.64B EV / Sales 2025 * 1.32 x
P/E ratio 2024 *
14.1 x
P/E ratio 2025 *
12.3 x
Employees -
Yield 2024 *
2.74%
Yield 2025 *
2.39%
Free-Float 53.52%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer 54 01/12/01
Director of Finance/CFO 47 01/09/01
Chief Tech/Sci/R&D Officer 48 01/18/01
Members of the board TitleAgeSince
Director/Board Member 60 01/07/01
Director/Board Member 56 -
Director/Board Member 52 -
More insiders
Zinzino AB is a Sweden-based global Company engaged in selling dietary supplements, skin care and lifestyle products. The Company specializes in biomarker-based, personalized nutrition and health tech. The Company’s test-based, scientifically proven nutritional supplements are available on more than 100 markets across the world. Zinzino AB owns the Norwegian research and production units BioActive Foods AS and Faun Pharma AS. The Company’s headquarter is in Gothenburg, Sweden with additional offices in Finland, Latvia, Norway, USA, Australia, Hong Kong, Malaysia and India.
Calendar
More about the company